M. T. Tirona, R. Sehgal, and O. Ballester, Prevention of Breast Cancer (Part I): Epidemiology, Risk Factors, and Risk Assessment Tools, Cancer Investigation, vol.67, issue.17, pp.743-750, 2010.
DOI : 10.1038/sj.bjc.6604305

E. Seregni, A. Coli, and N. Mazzucca, Circulating tumour markers in breast cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.31, issue.0, pp.15-22, 2002.
DOI : 10.1007/s00259-004-1523-z

W. P. Carney, R. Neumann, A. Lipton, K. Leitzel, S. Ali et al., Monitoring the Circulating Levels of the HER2/neu Oncoprotein in Breast Cancer, Clinical Breast Cancer, vol.5, issue.2, pp.105-116, 2004.
DOI : 10.3816/CBC.2004.n.014

M. Van-de-vijver, Emerging Technologies for HER2 Testing, Oncology, vol.63, issue.1, pp.33-38, 2002.
DOI : 10.1159/000066199

M. Sanchez-carbayo, Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens, Tumor Biology, vol.520, issue.2, pp.103-112, 2010.
DOI : 10.1007/s13277-009-0014-z

E. Morgan, R. Varro, H. Sepulveda, J. A. Ember, J. Apgar et al., Cytometric bead array: a multiplexed assay platform with applications in various areas of biology, Clinical Immunology, vol.110, issue.3, pp.252-266, 2004.
DOI : 10.1016/j.clim.2003.11.017

J. M. Schwenk, M. Gry, R. Rimini, M. Uhlen, and P. Nilsson, Antibody Suspension Bead Arrays within Serum Proteomics, Journal of Proteome Research, vol.7, issue.8, pp.3168-3179, 2008.
DOI : 10.1021/pr700890b

C. Hamers-casterman, T. Atarhouch, S. Muyldermans, G. Robinson, C. Hamers et al., Naturally occurring antibodies devoid of light chains, Nature, vol.363, issue.6428, pp.446-448, 1993.
DOI : 10.1038/363446a0

L. Huang, S. Muyldermans, and D. Saerens, : proficient tools in diagnostics, Expert Review of Molecular Diagnostics, vol.10, issue.6, pp.777-785, 2010.
DOI : 10.1586/erm.10.62

I. Vaneycken, M. D. Huyvetter, S. Hernot, J. De-vos, C. Xavier et al., Immuno-imaging using nanobodies, Current Opinion in Biotechnology, vol.22, issue.6, pp.877-881, 2011.
DOI : 10.1016/j.copbio.2011.06.009

G. Behar, P. Chames, I. Teulon, A. Cornillon, F. Alshoukr et al., Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen, FEBS Journal, vol.31, issue.14, pp.3881-3893, 2009.
DOI : 10.1111/j.1742-4658.2009.07101.x

URL : https://hal.archives-ouvertes.fr/hal-00414287

D. Kastelic, S. Frkovic-grazio, D. Baty, G. Truan, R. Komel et al., A single-step procedure of recombinant library construction for the selection of efficiently produced llama VH binders directed against cancer markers, Journal of Immunological Methods, vol.350, issue.1-2, pp.54-62, 2009.
DOI : 10.1016/j.jim.2009.08.016

X. Cai and A. Garen, Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries., Proceedings of the National Academy of Sciences, vol.92, issue.14, pp.6537-6541, 1995.
DOI : 10.1073/pnas.92.14.6537

R. C. Roovers, E. Van-der-linden, A. P. De-bruine, J. W. Arends, and H. R. Hoogenboom, Identification of colon tumour-associated antigens by phage antibody selections on primary colorectal carcinoma, European Journal of Cancer, vol.37, issue.4, pp.542-549, 2001.
DOI : 10.1016/S0959-8049(00)00432-9

C. Gao, S. Mao, F. Ronca, S. Zhuang, V. Quaranta et al., De novo identification of tumor-specific internalizing human antibody???receptor pairs by phage-display methods, Journal of Immunological Methods, vol.274, issue.1-2, pp.185-197, 2003.
DOI : 10.1016/S0022-1759(02)00522-7

C. A. Geuijen, N. Bijl, R. C. Smit, F. Cox, M. Throsby et al., A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometry, European Journal of Cancer, vol.41, issue.1, pp.178-187, 2005.
DOI : 10.1016/j.ejca.2004.10.008

T. Heitner, A. Moor, J. L. Garrison, C. Marks, T. Hasan et al., Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library, Journal of Immunological Methods, vol.248, issue.1-2, pp.17-30, 2001.
DOI : 10.1016/S0022-1759(00)00340-9

B. Liu, F. Conrad, M. R. Cooperberg, D. B. Kirpotin, and J. D. Marks, Mapping Tumor Epitope Space by Direct Selection of Single-Chain Fv Antibody Libraries on Prostate Cancer Cells, Cancer Research, vol.64, issue.2, pp.704-710, 2004.
DOI : 10.1158/0008-5472.CAN-03-2732

C. Marks and J. D. Marks, Phage Libraries ??? A New Route to Clinically Useful Antibodies, New England Journal of Medicine, vol.335, issue.10, pp.730-733, 1996.
DOI : 10.1056/NEJM199609053351008

C. Mazuet, D. Lerouge, M. A. Poul, and N. Blin, Breast carcinoma specific antibody selection combining phage display and immunomagnetic cell sorting, Biochemical and Biophysical Research Communications, vol.348, issue.2, pp.550-559, 2006.
DOI : 10.1016/j.bbrc.2006.07.087

C. A. Benedict, A. J. Mackrell, and W. F. Anderson, Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay, 38. K. Even-Desrumeaux, D. Baty and P. Chames, pp.223-231, 1997.
DOI : 10.1016/S0022-1759(96)00227-X

V. Barak, H. Goike, K. W. Panaretakis, and R. Einarsson, Clinical utility of cytokeratins as tumor markers, Clinical Biochemistry, vol.37, issue.7, pp.529-540, 2004.
DOI : 10.1016/j.clinbiochem.2004.05.009

L. Wang, Y. Wang, Y. Liu, M. Cheng, X. Wu et al., Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection, Journal of Experimental & Clinical Cancer Research, vol.28, issue.1, pp.57-101, 2009.
DOI : 10.1186/1756-9966-28-57

N. Alvarez-rueda, G. Behar, V. Ferre, M. Pugniere, F. Roquet et al., Generation of llama single-domain antibodies against methotrexate, a prototypical hapten, 46. A. Shevchenko, M. Wilm, O. Vorm and M. Mann, pp.1680-1690, 1996.
DOI : 10.1016/j.molimm.2006.08.007

URL : https://hal.archives-ouvertes.fr/hal-00258931